Assessing the problem of counterfeit medications in the United Kingdom

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both

(2010) Michael Böhm et al.   CIRCULATION

Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks

(2010) G. Jackson et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus

(2010) G. Jackson et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Is Obesity a Further Cardiovascular Risk Factor in Patients with Erectile Dysfunction?

(2010) Giovanni Corona et al.   Journal of Sexual Medicine

ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors

(2010) Gabriel Schnetzler et al.   Journal of Sexual Medicine

Male Sexuality and Cardiovascular Risk. A Cohort Study in Patients with Erectile Dysfunction

(2010) Giovanni Corona et al.   Journal of Sexual Medicine

Underdiagnosis of Obesity in Adults in US Outpatient Settings

(2009) Jun Ma et al.   ARCHIVES OF INTERNAL MEDICINE

Erectile Dysfunction and Mortality

(2009) Andre B. Araujo et al.   Journal of Sexual Medicine

An Unusual Outbreak of Hypoglycemia

(2009) Shih Ling Kao et al.   NEW ENGLAND JOURNAL OF MEDICINE

The availability of prescription-only analgesics purchased from the internet in the UK

(2008) Connie Raine et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Combating counterfeit drugs

(2008) The Lancet   LANCET